Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Axcelis Technologies (NASDAQ:ACLS) has built an enviable niche in the semiconductor capital equipment market, but recent cyclical headwinds present an intriguing opportunity for value-oriented growth investors. Despite navigating a semiconductor digestion phase that pulled annual revenue down to $839 million in 2025, the company’s underlying structural thesis remains robust. Axcelis maintains a pristine balance sheet […]
Axcelis Technologies (ACLS) has drawn fresh attention after announcing a planned US$35 million ion implantation manufacturing facility in Pyeongtaek, Korea. This capacity move puts the stock’s recent performance into sharper focus. The Axcelis Technologies share price has picked up in the very short term, with a 1-day share price return of 3.5% and a 7-day share price return of 7.4%. This is occurring even though the 30-day share price return is down 11% and the 90-day share price return is...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Axcelis Technologies has announced plans to invest US$35,000,000 in a new 200,000-square-foot ion implantation equipment manufacturing facility in Pyeongtaek, Korea, with integrated cleanrooms, warehousing, and training capabilities, following an investment declaration ceremony with Korean government bodies and production targeted to start in the second half of 2028. This expansion adds a significant Asian manufacturing hub that could enhance Axcelis’s ability to respond quickly to customer...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.